Cadence Pharmaceuticals' CEO Ted Schroeder To Present At The JMP Securities 11th Annual Research Conference In San Francisco On

_{//health-fitness.news-articles.net/content/2012/ .. ual-research-conference-in-san-francisco-on.html}
^{Published in Health and Fitness on Friday, May 11th 2012 at 14:15 GMT by Market Wire}  

Cadence Pharmaceuticals' CEO Ted Schroeder To Present At The JMP Securities 11th... -- SAN DIEGO, May 11, 2012 /PRNewswire/ --

[ ]

My news for Investors

AtLeast one of the check box should be selected You are following news about Follow the latest news about CADX

SAN DIEGO, May 11, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: [ CADX ]), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's President and CEO Ted Schroeder will present the company's corporate overview on Tuesday, May 15, 2012 at 2:00pm Pacific Time (5:00pm Eastern Time) during the JMP Securities 11th Annual Research Conference at the Ritz-Carlton Hotel in San Francisco.

The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at [ www.cadencepharm.com ] in the Investor Relations section. A replay of the webcast will be available approximately three hours following the live webcast and will be archived for 30 days.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting.  The current version of Cadence Pharmaceuticals' corporate overview may be viewed on the "Investors" page of [ www.cadencepharm.com ], under "Events and Presentations." 

SOURCE Cadence Pharmaceuticals, Inc.

RELATED LINKS
[ http://www.cadencepharm.com ]